Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Evans

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Frontiers in Neurology|July 22, 2025
Comparative cohort study of post-acute COVID-19 infection with a nested, randomized controlled trial of ivabradine for those with postural orthostatic tachycardia syndrome (the COVIVA study)David Saunders, Thomas B Arnold, Jason M Lavender, et al.
Journal of Medicinal Chemistry|May 9, 2024
Discovery and Optimization of Tambjamines as a Novel Class of Antileishmanial AgentsPapireddy Kancharla, Diana Ortiz, Corinne M Fargo, et al.
BMJ Open|February 26, 2021
Additional Treatments to the Local tumour for metastatic prostate cancer-Assessment of Novel Treatment Algorithms (IP2-ATLANTA): protocol for a multicentre, phase II randomised controlled trialMartin John Connor, Taimur Tariq Shah, Katarzyna Smigielska, et al.
ACS Infectious Diseases|November 11, 2024
Tambjamines as Fast-Acting Multistage AntimalarialsAmrendra Kumar, Yuexin Li, Rozalia A Dodean, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Frontiers in Neurology|July 22, 2025
Comparative cohort study of post-acute COVID-19 infection with a nested, randomized controlled trial of ivabradine for those with postural orthostatic tachycardia syndrome (the COVIVA study)David Saunders, Thomas B Arnold, Jason M Lavender, et al.
Journal of Medicinal Chemistry|May 9, 2024
Discovery and Optimization of Tambjamines as a Novel Class of Antileishmanial AgentsPapireddy Kancharla, Diana Ortiz, Corinne M Fargo, et al.
BMJ Open|February 26, 2021
Additional Treatments to the Local tumour for metastatic prostate cancer-Assessment of Novel Treatment Algorithms (IP2-ATLANTA): protocol for a multicentre, phase II randomised controlled trialMartin John Connor, Taimur Tariq Shah, Katarzyna Smigielska, et al.
ACS Infectious Diseases|November 11, 2024
Tambjamines as Fast-Acting Multistage AntimalarialsAmrendra Kumar, Yuexin Li, Rozalia A Dodean, et al.
Pageof 8